We’re pleased to see the BMJ published our Rapid Response letter (below). Let us hope the BMJ and other medical journals will start covering akathisia in more depth to reduce medication-induced harm and death. Read the BMJ article at https://www.bmj.com/content/388/bmj.r67.full and responses at https://www.bmj.com/content/388/bmj.r67/rapid-responses.
See insights
Boost a post
Like
Comment
Share
The BMJ reports that a coroner is questioning whether there is enough information provided about the suicide risks all SSRIs pose.
Katy Skerrett, senior coroner for Gloucestershire, has sent a regulation 28 report, intended to prevent future deaths. MISSD believes medications that can cause akathisia-induced death, to include SSRIs, should have a bold and clear warning and that doctors and patients should be fully informed prior to prescribing.
See https://www.bmj.com/content/388/bmj.r67.full and use open access to read the full article.
The prescription drugs taken as directed by Thomas Kingston before he died have ben flagged more than 40 times by coroners, it has been found.
The 45-year-old husband of Lady Gabriella Windsor ended his life in February last year at his parents’ home in the Cotswolds. The financier had been prescribed two selective serotonin reuptake inhibitors (SSRIs) – and zopiclone, a sleeping tablet, before his death.
“Following an inquest into his death, senior coroner for Gloucestershire Katy Skerrett concluded that the financier was “suffering adverse effects” of medication he had recently been prescribed.
In a prevention of future deaths report (PFD), she questioned whether there is adequate communication of the risks of suicide associated with such medication. Ms Skerrett is the latest in a string of coroners to have referenced either citalopram or sertraline in reports. Analysis by The Times found that at least 40 PFD reports mentioned the use of the SSRIs by the deceased person.”
Read the full article at https://www.independent.co.uk/news/health/sertraline-citalopram-ssri-thomas-kingston-coroners-suicide-b2679933.html.
MISSD is dedicated to promoting truth in disclosure, honesty in reporting and legitimate drug trials. This recent article explains well how ghost written medical journal articles, fraudulent clinical drug trials, and weak drug regulations increase akathisia and related iatrogenic harm. Read the full article at https://rxisk.org/who-will-make-medicine-great-again/.